comparemela.com

Latest Breaking News On - தலைமை மருத்துவ வளர்ச்சி அதிகாரி - Page 1 : comparemela.com

CEOs of Biopharmaceutical Companies CTLT, GSK, INCY, MRK, M

, and  ESG and the Earnings Call have been widely cited and republished in leading corporate finance journals and media. See the complete collection of research and resources available on the CEO Investor Forum’s website.   ABOUT THE BIOPHARMA SUSTAINABILITY ROUNDTABLE The Biopharma Sustainability Roundtable is a sector-specific collaboration platform that works with senior biotech and pharma executives to help drive their Sustainability agendas forward. We facilitate a program of webinars and topical forums each spring, a sector-focused survey, and an annual conference in the Fall, all addressing a broad agenda of ESG topics defined in collaboration with our participants. Executives and invited thought leaders come together to explore Sustainability challenges and trends, examine cutting edge industry topics, share best practices, and learn from each other. The Roundtable also facilitates focused initiatives that engage participating biopharma companies and key stake ho

HMNC Brain Health Embarks on Next Phase of Growth with New Leadership Team

HMNC Brain Health Embarks on Next Phase of Growth with New Leadership Team Dr. Hans Eriksson appointed Chief Clinical Development Officer Dr. Franz Humer strengthens Board of Directors as Chairman Founder Prof. Dr. Dr. Dr. h.c. mult. Florian Holsboer to lead Scientific Advisory Board MUNICH, GERMANY / ACCESSWIRE / April 22, 2021 / HMNC Brain Health, a biotech company focused on the development of innovative and personalized treatments for depression and other neuropsychiatric disorders, enters a new phase of growth with a new leadership team. Benedikt von Braunmühl, formerly COO, Diagnostic Services of Medicover, will take over as Chief Executive Officer with effect of May 1, 2021. He will succeed the company founder Prof. Florian Holsboer who already stepped up to the Board of Directors and now also took over the lead of the Scientific Board. Dr. Hans Eriksson, most recently Chief Medical Officer at COMPASS Pathways, further strengthens the Executive Board as Chief Clinical Dev

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.